home All News open_in_new Full Article

Glenmark Unit Signs Exclusive Licensing Pact With AbbVie For Cancer Drug

Under the pact, Glenmark's innovation arm has partnered with AbbVie to globally manufacture ISB 2001, a drug used in cancer treatment.


today 9 h. ago attach_file Events

attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Culture
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Events
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Science


ID: 1174646954
Add Watch Country

arrow_drop_down